Literature DB >> 32813178

Rescue catheter-based therapies for the treatment of acute massive pulmonary embolism after unsuccessful systemic thrombolysis.

Maofeng Gong1, Guoping Chen1, Boxiang Zhao1, Jie Kong1, Jianping Gu1, Xu He2.   

Abstract

The management of acute massive pulmonary embolism (PE) patients who did not respond to systemic thrombolysis (ST) has not been well established. The present study aimed to investigate the safety and effectiveness of catheter-based therapies (CDT) in this condition. We conducted a retrospective study of PE patients after unsuccessful ST (UST) between January 2012 and January 2018. Massive PE was identified in 408 patients and treated with full-dose ST therapy. Thrombolysis at 36 h was judged to be unsuccessful in 52 patients. Four ineligible patients were excluded, and the remaining 48 patients underwent rescue CDT: 30 patients underwent thrombus fragmentation with a rotating pigtail catheter; 8 patients underwent Straub rotational thrombectomy; and 10 patients underwent AngioJet rheolytic thrombectomy. In total, 42 patients subsequently underwent CDT relative to reduced-dose thrombolysis. Pooled clinical success was achieved in 45 patients, and the time-to-clinical instability relief for CDT was short (i.e., 48 h). Clinical findings significantly improved with oxygen saturation and the shock index (p < 0.01). CDT resulted in a significant decrease in the right ventricular (RV)/left ventricular end-diastolic diameter ratio and the average number of patients with pulmonary hypertension (p < 0.01). None of the patients suffered major complications or procedure-related adverse events, and two patients experienced minor complications. During follow-up, RV function symptoms were uneventful. The present study found that CDT is a safe and effective modality for rescue management of massive PE in patients with clinical instability and RV dysfunction after UST, leading to improved clinical outcomes and RV function with a low complication rate.

Entities:  

Keywords:  Emergency care; High-risk or massive pulmonary embolism; Percutaneous mechanical thrombectomy; Radiology intervention; Thrombolysis

Year:  2021        PMID: 32813178     DOI: 10.1007/s11239-020-02255-9

Source DB:  PubMed          Journal:  J Thromb Thrombolysis        ISSN: 0929-5305            Impact factor:   2.300


  2 in total

1.  Trends in thrombolytic treatment and outcomes of acute pulmonary embolism in Germany.

Authors:  Karsten Keller; Lukas Hobohm; Matthias Ebner; Karl-Patrik Kresoja; Thomas Münzel; Stavros V Konstantinides; Mareike Lankeit
Journal:  Eur Heart J       Date:  2020-01-21       Impact factor: 29.983

2.  Feasibility of low-dose infusion of alteplase for unsuccessful thrombolysis with urokinase in deep venous thrombosis.

Authors:  Maofeng Gong; Boxiang Zhao; Xu He; Jianping Gu; Guoping Chen
Journal:  Exp Ther Med       Date:  2019-08-26       Impact factor: 2.447

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.